Asset Purchase Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.
The report provides access to asset purchase deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
This report contains a comprehensive listing of asset purchase deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual asset purchase contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of asset purchase dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in asset purchase as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of asset purchase deals.
Chapter 4 provides a review of the leading asset purchase deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active asset purchase dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of asset purchase deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the asset purchase deal.
The deal directory includes a comprehensive listing of all asset purchase deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in asset purchase dealmaking since 2019.
In conclusion, this report provides everything a prospective dealmaker needs to know about asset purchase alliances.
Asset Purchase Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for asset purchase deals, including contract documents where available.
The report provides access to asset purchase deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
The report focuses on four primary types of asset available for purchase:
- Business assets
- Product assets
- Royalty assets
- Technology assets
This report contains a comprehensive listing of asset purchase deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual asset purchase contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of asset purchase dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in asset purchase as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of asset purchase deals.
Chapter 4 provides a review of the leading asset purchase deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active asset purchase dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of asset purchase deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the asset purchase deal.
The deal directory includes a comprehensive listing of all asset purchase deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in asset purchase dealmaking since 2019.
In conclusion, this report provides everything a prospective dealmaker needs to know about asset purchase alliances.
Asset Purchase Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:
- Understand deal trends since 2019
- Browse asset purchase deals
- Benchmark analysis - identify market value of transactions
- Financials - headline, upfront, milestone, royalty rates
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report Scope
Asset Purchase Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the asset purchase trends and structure of deals entered into by leading biopharma companies worldwide.Asset Purchase Deals in Pharmaceuticals and Biotechnology includes:
- Trends in asset purchase dealmaking in the life sciences industry
- Overview of asset purchase deal structure
- Directory of asset purchase deal records covering pharmaceuticals, biotechnology, medical devices and diagnostics
- The leading asset purchase deals by value
- Most active asset purchase dealmakers
- The leading asset purchase partnering resources
In Asset Purchase Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Asset Purchase Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for asset purchase deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the rights granted or optioned?
- What rights are granted by the agreement?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are intellectual property rights handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in asset purchase dealmaking
Chapter 3 - Overview of asset purchase deal structure
Chapter 4 - Leading asset purchase deals
Chapter 5 - Top 25 most active asset purchase dealmakers
Chapter 6 - Asset purchase deals including contracts directory
Deal directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3B Pharmaceuticals
- 3CL Sciences
- 3M
- 4D Molecular Therapeutics
- 9 Meters Biopharma
- 23andMe
- 30 Technology
- Aadi Bioscience
- Aardvark Therapeutics
- Abbvie
- Abcam
- AbCellera Biologics
- Acacia Research
- Accelus
- Achaogen
- AC Immune
- Acino Pharma
- Aclaris Therapeutics
- Acorda Therapeutics
- Acrotech Biopharma
- Actelion
- Acutus Medical
- Adalvo
- Adamis Pharmaceuticals
- Adapsyn Bioscience
- AdaptHealth
- Additive Orthopaedics
- Adello Biologics
- Adhera Therapeutics
- Adial Pharmaceuticals
- adMare BioInnovations
- Admedus
- Adovate
- Advanced Facialdontics
- Advanced Neural Dynamics
- Advanced Tear Diagnostics
- AdvanSource Biomaterials
- ADvantage Therapeutics
- Advanz Pharma
- Advent International
- Aelix Therapeutics
- Aethon Therapeutics
- Aevitas Therapeutics
- AFFiRiS
- AGC Biologics
- Agios Pharmaceuticals
- Akida
- Akorn
- Alaya.bio
- Alcon Laboratories
- Aleph Farms
- Alexion Pharmaceuticals
- Alfasigma
- Alfred E. Mann Institute for Biomedical Engineering
- Algernon Pharmaceuticals
- ALK-Abello
- Allergan
- Allergan Aesthetics
- AllerQuest
- Alliance Pharma
- Ally Biotech
- Almirall
- Altaris Capital Partners
- Altavant Sciences
- Alvogen
- Alvotech
- Amerigen Pharmaceuticals
- AmerisourceBergen
- Amgen
- AMMTeK
- Amneal Pharmaceuticals
- Ampersand Capital Partners
- Amphastar Pharmaceuticals
- AmplifyBio
- Amplyx Pharmaceuticals
- Amylyx Pharmaceuticals
- Amyris
- Angelini Pharma
- Angiodynamics
- ANI Pharmaceuticals
- Antares Pharma
- Antares Therapeutics
- Apeiron Biologics
- Apellis Pharmaceuticals
- ApoPharma
- Apotex
- Applied UV
- Aradigm
- Araris Biotech
- aratinga.bio SAS Group
- Arcadia Consumer Healthcare
- Ardena
- argenx
- ArisGlobal
- Arkuda Therapeutics
- Arranta Bio
- Arrevus
- Arrowhead Pharmaceuticals
- ARS Pharmaceuticals
- Artisan Bio
- Arvinas
- Asarina Pharma
- Ascend Advanced Therapies
- Asklepios Biopharmaceutical
- Aspargo Laboratories
- Aspen Holding
- Aspen Pharmacare Canada
- Aspen Surgical Products
- Assembly Biosciences
- Assertio Therapeutics
- Assisi Animal Health
- AstraZeneca
- Astrea Pharma
- Atara Biotherapeutics
- ATEC Spine
- Athenex
- Atnahs Pharma
- ATP
- Atreca
- Audax Private Equity
- Augmedics
- AUG Therapeutics
- AuraGen Aesthetics
- Aurora Cannabis
- AuxoCell Laboratories
- Avalo Therapeutics
- Avicanna
- Avrobio
- AXIM Biotechnologies
- Axonics
- Ayala Pharmaceuticals
- Aytu BioPharma
- Azurity Pharmaceuticals
- Baptist Health Care
- Baring Private Equity Asia
- Basilea Pharmaceutica
- Bausch & Lomb
- Bausch Health Companies
- Bavarian Nordic
- Baxter International
- Bayer
- Bayer Animal Health
- B Braun
- Beacon Therapeutics
- Beartooth Therapeutics
- Beckley Psytech
- Becton Dickinson
- Beiersdorf
- Bellicum Pharmaceuticals
- Bellin Health
- Bellus Health
- Benuvia Therapeutics
- Benvenue Medical
- BetterLife Pharma
- Bigfoot Biomedical
- Biocon
- BioDelivery Sciences
- Biodelta Nutraceuticals
- Biodesix
- Biogen
- BioGene Technology
- Bio Innovation Group
- BioMarin Pharmaceutical
- bioMerieux
- BioMotiv
- Bioness
- BioNTech
- BioNxt Solutions
- BiopharmX
- Biora Therapeutics
- BioReference Laboratories
- BioSig Technologies
- BioStem Technologies
- BioSyent
- Biotronik
- BioVaxys
- Bioventus
- BioVie
- Bluebird Bio
- Blue Water Biotech
- Blue Water Vaccines
- Blumentech
- BMG Pharmaceuticals
- Boehringer Ingelheim
- Bolt Biotherapeutics
- Bone Therapeutics
- Bora Pharmaceuticals
- Boston Pharmaceuticals
- Boston Scientific
- Botanix Pharmaceuticals
- Brickell Biotech
- BridgeBio Pharma
- Bridge Medicines
- Bridge to Life
- Bridgewest Group
- Briggs Healthcare
- Brii Biosciences
- Bristol-Myers Squibb
- Bruker
- BVI Medical
- C2Dx
- Cambus Medical
- CanAm Bioresearch
- Candel Therapeutics
- Cannabis Manufacturer’s Guild
- Cannara Biotech
- Cantargia
- Cardinal Health
- CardioFocus
- Cardionomic
- Cardiovascular Systems
- Carestream Health
- Castle Biosciences
- Catalent
- Catalyst Biosciences
- Catheter Precision
- CBC Group
- Cedars-Sinai Medical Center
- Celator
- Celgene
- Cell Biosciences
- Celling Biosciences
- Cellistic
- CellReady
- Celltrion
- Celsee
- Celularity
- Celyad
- Centinel Spine
- Centre for Probe Development and Commercialization
- CeraVx
- Cerebain Biotech
- Cerecor
- Chembio Diagnostics
- Cheplapharm Arzneimittel
- Chiesi Farmaceutici
- Chimagen Biosciences
- China Pharma Holdings
- Cilag AG
- Cinven
- Cipher Pharmaceuticals
- Cipla
- Circadian Wellness
- Cirrus Dx
- Clarus Therapeutics
- Clayton Dubilier & Rice
- Clovis Oncology
- Co.Don
- Codan Triplus
- Codexis
- Codiak BioSciences
- Coeptis Pharmaceuticals
- Coherus Biosciences
- College Park Industries
- Collegium Pharmaceuticals
- Community Health Systems
- Concert Pharmaceuticals
- Confluent Medical Technologies
- ConforMIS
- Context Therapeutics
- ConvaTec
- Conventus Orthopaedics
- Cook Medical
- Cooper Companies
- Corden Pharma
- Cordis
- CORXEL Pharmaceuticals
- Corza Health
- Corza Medical
- Cosette Pharmaceuticals
- Covestro
- Covis Pharmaceutical
- Covistat
- CROMA Pharma
- Crosswalk Therapeutics
- CTI BioPharma
- Cullinan Oncology
- Curaleaf
- Curon Biopharmaceutical
- Cybin
- Cyclerion Therapeutics
- CYduct Diagnostics
- Cynata Therapeutics
- Cyprium Therapeutics
- Cytokinetics
- CytoMed Therapeutics
- Daiichi Sankyo
- Dascena
- DAS Therapeutics
- Day Zero Diagnostics
- Delpharm
- Denovo Biopharma
- Dentsply International
- DermaPort
- Dermira
- DermOQ
- Desert Medical Campus
- Desma HC
- DeuteRx
- DiagnaMed
- DiamiR
- DifGen Pharmaceuticals
- Dilon Diagnostics
- DJO Surgical
- Dong-A Pharmaceutical
- Dr. Reddy's Laboratories
- Dren Bio
- DSM
- DSM Nutritional Products
- Dualogics
- Dune Medical Devices
- Durect
- Dutch Emotional Brain
- EaglePicher Technologies
- Eckert & Ziegler
- Edan Diagnostics
- Eddingpharm
- Eden Biologics
- EdiGene
- Edison Nation
- Editas Medicine
- Edwards Lifesciences
- Eiger BioPharmaceuticals
- Elanco
- Electrical Geodesics
- Elekta
- Elektron Eye Technology
- Eli Lilly
- ELT Sight
- Eluminex Biosciences
- Emboline
- Emerald Health Therapeutics
- Emergent BioSolutions
- Empyrean Medical Systems
- Encore Medical
- EndoCeutics
- Endogastric Solutions
- Endonovo Therapeutics
- Endo Ventures
- Entheon Biomedical
- Environmental Tectonics Corporation
- Envista
- EnWave
- Enzyvant Science
- Epigenomics
- EPI Health
- Equillium
- Erytech Pharma
- Essential Pharma
- Essential Pharmaceuticals
- Eterna Therapeutics
- Ethicon Endo-Surgery
- Eton Pharmaceuticals
- Eurobio Scientific
- Evonik Industries
- Exacis Biotherapeutics
- Exelixis
- Expedeon
- Eyevance
- Finch Therapeutics
- Firsthand Technology
- Flagship Biosciences
- Flamma
- FORMA Therapeutics
- Fox Chase Chemical Diversity Center
- Freedom Innovations
- Fresh Tracks Therapeutics
- Freudenberg Medical
- Freya Pharma Solutions
- Fujifilm
- Fujifilm Diosynth Biotechnologies
- Fusion Pharmaceuticals
- G&W Laboratories
- Galapagos
- Galderma
- Galecto
- Galgo Medical
- Galvanize Therapeutics
- GamaMabs Pharma
- Gardia Medical
- GC Pharma
- GE Healthcare
- Genentech
- GenePOC
- Genesis MedTech
- Genezen
- Genomadix
- Genomic Health
- Gilead Sciences
- Ginkgo BioWorks
- Givaudan
- GL Capital Group
- Glenmark Pharmaceuticals
- Glycotope Biotechnology
- Gowan Crop Protection
- GPI Group
- Gravitas Therapeutics
- Great Belief International
- Greenteaspoon
- GRI Bio
- Grifols
- Grunenthal
- GSK
- GT Biopharma
- GT Medical Technologies
- GVS
- Gyrus Capital
- H-CYTE
- Hackensack University Medical Center
- Haemonetics
- Halo Labs
- Harmonic Bionics
- Harrow Health
- Harvard University
- Havn Life Sciences
- HCA Healthcare
- Healion Bio
- Healiva
- HeartBeam
- HeavenlyRx
- heliosDX
- Hellman & Friedman
- Hera Biotech
- Heritage Group
- Heritage Pharmaceuticals
- High Ridge Brands
- Hikma Pharmaceuticals
- Hill-Rom
- Hillstream BioPharma
- HLS Therapeutics
- HMNRTH
- Hologic
- Howard Foundation
- Howmedica Osteonics
- HS Pharmaceuticals
- HTL Biotechnology
- Hubro Therapeutics
- Humanetics
- Humanitas University
- Hutchinson Technology
- Hutchison China MediTech
- Hypera Pharma
- I-mab
- iAnthus Capital
- IASO Biotherapeutics
- IBA
- iCAD
- Icagen
- IconOVir Bio
- Idorsia
- IFM Therapeutics
- Iktos
- IlmixGroup
- ImaginAb
- Imagin Medical
- Immedica
- ImmunGene
- ImmunityBio
- ImmunoCellular Therapeutics
- Immunome
- Imugene
- IMV
- Inceptor Bio
- Incyte
- INEX Innovate
- Infab
- InflammX Therapeutics
- Innate Pharma
- Innovation Skane
- Innovent Biologics
- Inozyme Pharma
- Inserm
- Institut du Cancer Courlancy
- Insulet
- Intas Pharmaceuticals
- Integra LifeSciences
- Integrative Medicine
- Intermountain Precision Genomics
- International Biomedical
- International Process Plants
- Interpace BioPharma
- IntraFuse
- Invitae
- Ionic Brands
- Ipsen
- Iridex
- Irras
- Isologic Innovative Radiopharmaceuticals
- IsoPlexis
- IsoRay
- Itamar Medical
- Iveric Bio
- Ixaka
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Jerome Stevens Pharmaceuticals
- Jolt Health
- Journey Medical
- JT Pharmaceuticals
- Juvise Pharmaceuticals
- Kaken Pharmaceutical
- Kala Pharmaceuticals
- Kancera
- Kane Biotech
- Kapoose Creek Bio
- Karo Pharma
- Kashiv BioSciences
- KBP BioSciences
- KD Pharma
- Kedrion
- KemPharm
- Kincell Bio
- Kindstar Globalgene Technology
- Kinnate Biopharma
- Kite Pharma
- Klogenix
- Korsch
- Kronos Bio
- Kuros Biosciences
- Kyocera
- Laboratoires DELBERT
- Laboratoire Serb
- Laboratoires Thea
- Laboratorio Medinfar
- Laboratorios Rubio
- Laboratory Corporation of America
- Lafayette Instrument Company
- Landos Biopharma
- Lannett
- Lantheus Holding
- LeMaitre Vascular
- LEO Pharma
- Les Laboratoires Servier
- Lexicon Pharmaceuticals
- LGC
- LI-COR Biosciences
- Lifecycle Biotechnologies
- Lifenet
- Ligand Pharmaceuticals
- Lighthouse Pharmaceuticals
- Liminal BioSciences
- Lincotek Medical
- LineaRx
- Link Fund Solutions
- Link Immunotherapeutics
- LivaNova
- LIVMOR
- Lobe Sciences
- Lobesity Pharma
- Longitude Capital
- Lonza
- Lorem Vascular
- LOTTE
- LTL Pharma
- LTS Lohmann Therapie-Systeme
- Lucy Scientific Discovery
- Lumenis
- Luminera
- LuminUltra
- LumiraDx
- LumiThera
- Lumos Pharma
- MAB Discovery
- MabVax Therapeutics
- Macrogen
- Macrogenics
- MacuHealth
- MacuLogix
- Magstim
- Mainz Biomed
- Mandos
- MannKind Biopharmaceuticals
- Maravai LifeSciences
- Marinus Pharmaceuticals
- Marker Therapeutics
- Masimo
- Matrox
- MAWD Pathology
- Mayne Pharma
- McKesson
- MD Anderson Cancer Center
- MDNA Life Sciences
- MDxHealth
- Medican Enterprises
- Medicom
- Medicure
- Medimetrics
- Medline Industries
- Mednax
- Medtronic
- Megadalton Solutions
- Meilleur Technologies
- Meitheal Pharmaceuticals
- Melinta Therapeutics
- Menarini Asia-Pacific
- Mentice
- Merck and Co
- Merck Animal Health
- Merck KGaA
- Meridian Bioscience
- Merit Medical Systems
- Merrimack Pharmaceuticals
- Merz Therapeutics
- Microba Life Sciences
- Microbot Medical
- MiGenTra
- Mikart
- MilliporeSigma
- Minapharm
- Mind Medicine
- Minerva Surgical
- Mirum Pharmaceuticals
- MITEM PHARMA
- Mithra Pharmaceuticals
- Mitralign
- Mitsubishi Chemical
- MLase
- MMT Technologies
- Moberg Pharma
- Modernizing Medicine
- Modern Meadow
- Modulus Therapeutics
- Molecular Assemblies
- MolecuLight
- Molnlycke Health Care
- Momentis Surgical
- MorphoSys
- Mountain Valley MD
- MTD
- Mubadala Investment Company
- Mucokinetica
- Mustang Bio
- Mylan Laboratories
- MyLife Technologies
- Myovant Sciences
- Myriad Genetics
- Naari Pharma
- Nabriva Therapeutics
- Nanjing King-friend Biochemical Pharmaceutical
- NanoProteagen
- NantHealth
- Natera
- National Resilience
- Navidea Biopharmaceuticals
- NEC OncoImmunity
- Negev Labs
- Nektar Therapeutics
- NEMO Health
- Neogen
- Neograft Technologies
- Neosurgical
- NeoSync
- Nephron Pharmaceuticals
- Neptune Wellness Solutions
- Nestle
- Nestle Health Science
- NeuBase Therapeutics
- Neuraxpharm
- NeurMedix
- Neuro-Kinesis Corporation
- NeuroBo Pharmaceuticals
- Neuropathix
- Nevakar
- New Day Diagnostics
- Newport Research
- New York Blood Center
- Nexelis
- Nextmune
- Nido Surgical
- Nika Pharmaceuticals
- NImmune Biopharma
- Nitiloop
- NLC Pharma
- NOHO
- Noramco
- Nora Pharma
- Nordson Corporation
- North American Partners in Anesthesia
- NovaBay Pharmaceuticals
- NovAccess Global
- Novan
- Novartis
- Novavax
- Noventia Pharma
- NovImmune
- Novo Nordisk
- Nufarm
- NYU Langone Medical Center
- Oakrum Pharma
- ObsEva
- Ocugen
- Odyssey Health
- OhioHealth
- Omeros
- Oncimmune
- Oncopeptides
- OncoQuest
- Onkos Surgical
- Ono Pharmaceutical
- OpenBiome
- OPKO Health
- Opus Genetics
- Oragenics
- Organon
- Organovo
- Orgenesis
- Orifarm
- Orphazyme
- Orsenix
- Orthofix Medical
- Orum Therapeutics
- OSE Immunotherapeutics
- OsteoCentric Technologies
- OS Therapies
- Otonomy
- Otsuka
- Otsuka America Pharmaceutical
- Ovid Therapeutics
- PACT Pharma
- Padagis
- Palatin Technologies
- Palisade Bio
- PanTheryx
- Paragon 28
- ParaPRO
- Pascal Biosciences
- Patagonia Pharmaceuticals
- PathAI
- PaxMedica
- Peak Rock Capital
- Pearsanta
- PEAR Therapeutics
- PentixaPharm
- Performance Health
- Periphagen Holdings
- Perrigo
- Perry Baromedical
- Perspective Therapeutics
- PetIQ
- Pfizer
- Pharmaceutical Associates
- Pharmacolog
- PharmaLogic
- Pharmanovia
- Pharmapar
- Pharmaron
- PharmaTher
- PhaseBio Pharmaceuticals
- Phenomics Health
- Phoenixus
- Photonamic GmbH
- Physician Recommended Nutriceuticals
- Pierre Fabre
- Pierrel
- Piramal
- Pixium Vision
- PKG
- Plus Therapeutics
- PLx Pharma
- Poolbeg Pharma
- Precera Bioscience
- Precisa Medical Instruments
- Precision Biomonitoring
- Precision Neuroscience
- Pressure BioSciences
- Prestige Consumer Healthcare
- PreveCeutical Medical
- Primavera Capital Group
- Prisma Health
- ProBioGen
- Progenics Pharmaceuticals
- Progenity
- ProKidney
- Proliant Health and Biologicals
- ProMed Pharma LLC
- Promius Pharma
- Propel Orthodontics
- ProQR Therapeutics
- Proteor
- Proteus Digital Health
- Prothelia
- Prothena
- Psomagen
- Pulmokine
- Puration
- PureTech Health
- Purnovate
- QIAGEN
- QPS
- Qualigen
- Quasar Medical
- Quest Diagnostics
- Quince Therapeutics
- Radian
- Radius Health
- Rafarma Pharmaceuticals
- Rakuten Medical
- Ra Medical Systems
- Rasna Therapeutics
- Rayner Surgical
- RaySearch Laboratories
- Real Brands
- Realm Therapeutics
- Recipharm
- Reckitt Benckiser
- Recordati
- Rediscovery Life Sciences
- RedPoint Medical3D
- Regeneron Pharmaceuticals
- Regor Therapeutics
- ReliefBand Technologies
- ReLive Biotechnologies
- Relmada Therapeutics
- Renovis
- Resilience
- Resonetics
- Retinagenix
- Revive Therapeutics
- Rexgenero
- Roche
- Rohner
- Roivant Sciences
- Rosemont Pharmaceuticals
- RoundTable Healthcare Partners
- RoverMed BioSciences
- Royal Philips Electronics
- RTI Surgical
- Rumpus Therapeutics
- Safegard Medical
- Saladax Biomedical
- Salarius Pharmaceuticals
- Samsung Bioepis
- Samsung Biologics
- Sandoz
- Sanofi
- Santen Pharmaceutical
- Sanuwave Health
- Saol Therapeutics
- Sarcomatrix Therapeutics
- Saringer Life Science Technologies
- Savant HWP
- Scailyte
- Scantox
- Science 37
- Science Corporation
- Scion Solutions
- Sebacia
- Selenity Pharmaceuticals
- Seneca
- Sensus Healthcare
- Sentynl Therapeutics
- Septerna
- Serenity Bioworks
- Seres Therapeutics
- Seyltx
- Sharp Fluidics
- Sharps Technology
- Shenzhen Beimei Pharmaceuticals
- Shoppers Drug Mart
- Shoreline Biosciences
- Shorla Oncology
- Sibannac
- Sienna Biopharmaceuticals
- Sientra
- Sigma Analytical Services
- Signati Medical
- Signet Healthcare Partneers
- Silk Road Therapeutics
- Silony Medical
- Simtra BioPharma Solutions
- SIT Laboratorio Farmaceutico
- Skin Products
- Sloan Pharma
- SmartBreast
- Smith & Nephew
- SOCPRA Sciences Sante et Humaines
- SofPulse
- Sofregen Medical
- Sohm
- Sol-Gel
- Sonic Healthcare
- Sorrel Medical
- Sorse Technology
- Sosei
- Southern Research Institute
- Spectrum Pharmaceuticals
- Spinal Elements
- SpineThera
- Spiral Therapeutics
- Sproutly
- Spruce Biosciences
- Spry Health
- SQI Diagnostics
- STADA Arzneimittel
- Stanford Health Care
- Starboard Medical
- Stark Investments
- Steeper Group
- Steris Corporation
- STRATA Skin Sciences
- Stryker
- SugarLeaf Labs
- Sumitomo Dainippon Pharma
- Sumitovant Biopharma
- Summit Biolabs
- SunMed
- Sun Pharmaceutical
- Sunstar Suisse
- SuperiorVAS
- Supernus Pharmaceuticals
- Surgalign
- SWAT Medical AB
- Swedish Orphan Biovitrum
- Synergy Pharmaceuticals
- Syngene
- Synhale Therapeutics
- Synsight
- Syros Pharmaceuticals
- Taiho
- Takeda Pharmaceutical
- Talaris Therapeutics
- Tamir Biotechnology
- Targovax
- TekCyte
- Teleflex
- Teligent
- Telix Pharmaceuticals
- Terran Biosciences
- TerSera Therapeutics
- Terumo
- Teva Pharmaceutical Industries
- Teva Pharmaceuticals USA
- The DNA Company
- The Green Organic Dutchman Holdings
- Therabody
- Therakind
- TheraLight
- Therapeutic Solutions International
- Theravant
- Therma Bright
- ThermiGen
- Thermo Fisher Scientific
- THINK Surgical
- Tilray
- Titan Medical
- Titan Pharmaceuticals
- Tivic Health Systems
- Tiziana Life Sciences
- Tocagen
- Todos Medical
- Tolmar
- TONIX Pharmaceuticals
- Topcon
- Transcend Biodynamics
- TransEnterix
- Transformative Biotech
- Transgene
- TransMedics
- Travere Therapeutics
- Treace Medical Concepts
- Trigemina
- TriLink BioTechnologies
- TriReme Medical
- Trod Medical
- TuHURA Biopharma
- TuHURA Biosciences
- Tulex Pharmaceuticals
- Turn Biotechnologies
- uBiome
- uBriGene Biosciences
- UCB
- Unicycive Therapeutics
- UniQure
- Universal Display
- University of Helsinki
- Upsher-Smith
- Urgo Laboratories
- UroGen Pharma
- Urovant Sciences
- US Compounding
- US WorldMeds
- Valo Health
- Valo Therapeutics
- Varian Biopharmaceuticals
- Varian Medical Systems
- Vascular Graft Solutions
- Vault Health
- Vaximm
- Vaxxel
- VBI Vaccines
- VBL Therapeutics
- Vera Therapeutics
- Vertex Pharmaceuticals
- Veru
- Vesigen Therapeutics
- Viamet Pharmaceuticals
- Viatris
- Vibliome Therapeutics
- ViewPoint Therapeutics
- ViewRay
- Vifor Pharma
- Virbac
- Viscogliosi Brothers
- Visus Therapeutics
- Vitatex
- Viveca Biomed
- Vivos Therapeutics
- Vtesse
- Vyaire Medical
- Vyera Pharmaceuticals
- VYNE Therapeutics
- Walgreens
- Warburg Pincus
- Warp Drive Bio
- Waters Corporation
- Wave Neuroscience
- WavePoint Medical
- Wellspring Ophthalmics
- Wesana Health
- Windtree Therapeutics
- Wittenstein
- Wockhardt
- WraSer Pharmaceuticals
- Wuhan Humanwell
- WuXi Biologics
- Wuxi STA
- Xbiome
- XBiotech
- Xbrane Biopharma
- Xcelerate Solutions
- Xellia Pharmaceuticals
- Xoma
- Xspire Pharma
- Xtant Medical
- Yield10 Bioscience
- Yourgene Health
- Ypsomed
- Yumanity Therapeutics
- ZAP Surgical Systems
- Zealand Pharma
- Zebra technologies
- Zentiva
- Zomedica
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
